{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Vernon Hills",
      "address_1": "175 E Hawthorn Pkwy Ste 155",
      "reason_for_recall": "Presence of particulate matter: characterized as thin colorless flakes that are visually and chemically consistent with glass delamination.",
      "address_2": "",
      "product_quantity": "46,185 vials",
      "code_info": "a) Lot: 112911, Exp. 11/13, b)  Lot: 030712, Exp. 3/14",
      "center_classification_date": "20130827",
      "distribution_pattern": "Nationwide",
      "state": "IL",
      "product_description": "Benztropine Mesylate Injection, USP, 2 mg/mL(1 mg/1 mL), 2 mL Single Dose Vial, Rx only, Manufactured in the USA for Nexus Pharmaceuticals Inc, Lincolnshire, IL 60069,  NDC 14789-300-02",
      "report_date": "20130904",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Nexus Pharmaceuticals Inc",
      "recall_number": "D-925-2013",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "65853",
      "termination_date": "20160208",
      "more_code_info": "",
      "recall_initiation_date": "20130801",
      "postal_code": "60061-1493",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}